GWEN DALPHON: Open Payments
NPI 1245574250 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$51,793 in 298 payments from 21 companies in 2025. Trend: 2023 $19,914 · 2024 $34,579 · 2025 $51,793
Speaker / faculty: $35,150Food & beverage: $6,540Consulting: $4,983Travel & lodging: $4,968Education: $152
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 43 | $20,812 |
| Incyte Corporation | 91 | $20,613 |
| Eli Lilly and Company | 2 | $3,750 |
| Journey Medical Corporation | 3 | $1,625 |
| Regeneron Healthcare Solutions, Inc. | 17 | $1,525 |
| Janssen Biotech, Inc. | 25 | $861 |
| Lilly USA, LLC | 13 | $456 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $361 |
| Novartis Pharmaceuticals Corporation | 12 | $294 |
| ABBVIE INC. | 15 | $260 |
Products named: NEMLUVIO, Opzelura, EBGLYSS, DUPIXENT, TREMFYA, TALTZ, Bimzelx, Rhapsido.
Industry payments across DE — which companies pay providers there.
